Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Target drug discovery

Protein-targeting Drug Discovery Guided by Hydrogen/Deuterium Exchange Mass Spectrometry (DXMS)... [Pg.377]

Historically, the major focus of peptidomimetic design has evolved from receptor-targeted drug discovery research and has not been directly impacted by an experimentally-determined 3D structure of... [Pg.563]

Gonzalez, J. E., Oades, K., Leychkis, Y., Harootunian, A., Negulescu, P. A. Cell-based assays and instrumentation for screening ion-channel targets, Drug Discovery Today 1999, 4, 431-439. [Pg.327]

Hudes, G., Menon, S., and Golemis, E.A., 2004, Protein interaction-targeted drug discovery. In Rapley, R. and Harbron, S. (Eds), Molecular analysis and genome discovery, John Wiley Sons, 323-345. [Pg.250]

G. Deng and G. Sanyal, Applications of mass spectrometry in early stages of target drug discovery, /. Pharm. Biomed. Anal. 40 (2006), 528-538. [Pg.639]

Clare JF, Tate SN, Nobbs M, Romanos MA 2000 Voltage-gated sodium channels as therapeutic targets. Drug Discovery Today 5 506-520... [Pg.166]

The National Institutes of Health conducts targeted drug discovery and testing programs. The transfer of the scientific knowledge with commercial value from this agency to the pharmaceutical industry is one of the ways that pharmaceutical companies directly benefit from Federal research support. [Pg.202]

What is the justification for direct public spending on targeted drug discovery In certain cases, public health authorities have determined that national priorities necessitate public investment to speed the process of developing new therapies. Illnesses related to human immunodeficiency virus (HIV) is one example. There may also be barriers to private-sector involvement. The orphan drug programs exist because some conditions affect so few patients that the private sector might otherwise find investment in potential treatments financially unprofitable. [Pg.213]

I Targeted Drug Discovery Programs Cancer Development Therapeutics Program... [Pg.311]

Ashton, M. J., Jaye, M. Mason, J. S. (1996) New Perspectives in Lead Generation. 1. Discovery of Biological Targets. Drug Discovery Today 1, 11-15. [Pg.69]


See other pages where Target drug discovery is mentioned: [Pg.100]    [Pg.227]    [Pg.555]    [Pg.378]    [Pg.380]    [Pg.382]    [Pg.384]    [Pg.386]    [Pg.388]    [Pg.390]    [Pg.392]    [Pg.394]    [Pg.396]    [Pg.398]    [Pg.195]    [Pg.172]    [Pg.580]    [Pg.605]    [Pg.174]    [Pg.42]    [Pg.161]    [Pg.2565]    [Pg.44]    [Pg.202]    [Pg.211]    [Pg.213]    [Pg.169]    [Pg.275]    [Pg.275]    [Pg.901]    [Pg.297]    [Pg.366]    [Pg.458]    [Pg.98]   


SEARCH



A Systems Biology Approach to Target Identification and Validation for Human Chronic Disease Drug Discovery

DRUG DISCOVERY TARGETS AND RECEPTORS

Drug Discovery Toxicology: From Target Assessment to Translational Biomarkers, First Edition. Edited by Yvonne Will. J. Eric McDuffie

Drug discovery validated disease target

Drugs targeting

Epigenetic Targets in Drug Discovery Cell-Based Assays for HDAC Inhibitor Hit Validation

Influenza Virus Sialidase A Target for Drug Discovery

Influenza Virus Sialidase as a Drug Discovery Target

Multi-target drugs discovery

Target Validation The Foundation of Drug Discovery

Target discovery

Target discovery targets

Target drug discovery process

Target identification, drug discovery

Target identification, drug discovery genes

Target identification, drug discovery methods

Target validation, drug discovery

Target, targets drug discovery

Target, targets drug discovery

Target-Based antimicrobial drug discovery

Target-based drug discovery

Targeted drugs

Virus Sialidase as a Drug-Discovery Target

© 2024 chempedia.info